Multimeric IgM antibodies targeting DR5 are potent and rapid inducers of tumor cell apoptosis and cell death in vitro and in vivo Posted on March 5, 2019July 5, 2019 by jean kanerva Continue reading→
Agonistic IgM Antibodies Targeting Immunostimulatory TNFRSF Members GITR and OX40 Enhance Immune Responses beyond that of IgGs Posted on November 5, 2018July 5, 2019 by jean kanerva Continue reading→
Multimeric Anti-DR5 IgM antibody displays potent cytotoxicity in vitro and promotes tumor regression in vivo Posted on April 25, 2017August 2, 2018 by IGM Continue reading→
High Avidity Anti-CD20 IgM Antibody for Enhanced Complement-Dependent Cell Killing of Low CD20 Expressing Tumor Cells Posted on April 25, 2016August 2, 2018 by IGM Continue reading→
IGM-55.5, a novel monoclonal human recombinant IgM antibody with potent activity against B cell leukemia and lymphoma Posted on April 25, 2014August 2, 2018 by IGM Continue reading→